Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 239S · 10 late239 trades$59.22M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
ADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 21 | Bernstein HaroldPresident, R&D & CMO | MAZEMaze Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $400K 13.4K sh |
| Jul 2, 2026 traded Jul 1, 2026 |
| 19 | Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder |  HNGEHinge Health, Inc.Open-market sale · 10b5-1 plan | SELL | $1.60M 18.7K sh | Jul 2, 2026 traded Jul 1, 2026 |
| 19 | Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $4.80M 56.5K sh | Jul 2, 2026 traded Jul 1, 2026 |
| 19 | Rogers Daniel MarkDirector, Chief Executive Officer |  ASANAsana, Inc.Open-market sale · 10b5-1 plan | SELL | $95K 13.8K sh | Jul 2, 2026 traded Jun 30, 2026 |
| 17 | Lopez Gustavo JavierDirector |  LNDBrasilAgro - Brazilian Agricultural Real Estate CoOpen-market sale | SELL | $6,980 2,000 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 16 | McCulloch KevinSee Remarks |  XERSXeris Biopharma Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $723K 90.0K sh | Jul 2, 2026 traded Jul 1, 2026 |
| 15 | Bernstein HaroldPresident, R&D & CMO | MAZEMaze Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $36K 1,200 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 13 | Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $64K 741 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 13 | Ribeiro RamiroChief Medical Officer |  EYPTEyePoint, Inc.Open-market sale · 10b5-1 plan | SELL | $37K 2,438 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 9 | Ribeiro RamiroChief Medical Officer | EYPTEyePoint, Inc. Open-market sale · 10b5-1 plan | SELL | $37K 2,437 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 4 | Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $327K 3,900 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 4 | Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $290K 3,500 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 4 | Katz ZacharyCLO and Head of Global Affairs |  GRNDGrindr Inc.Open-market sale · 10b5-1 plan | SELL | $208K 12.8K sh | Jul 2, 2026 traded Jul 1, 2026 |
| 0 | Schubach Sarah ElizabethChief Accounting Officer |  DBXDROPBOX, INC.Open-market sale · 10b5-1 plan | SELL | $35K 1,305 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 47 | Bhalla Narinder PalChief Medical Officer |  LXEOLexeo Therapeutics, Inc.Open-market sale | SELL | $99K 22.3K sh | Jul 1, 2026 traded Jul 1, 2026 |
| 39 | Townsend Richard NolanDirector, Chief Executive Officer | LXEOLexeo Therapeutics, Inc. Open-market sale | SELL | $116K 25.9K sh | Jul 1, 2026 traded Jul 1, 2026 |
| 39 | Linz Terrence JamesPresident, Wholesale Brands |  LZBLA-Z-BOY INCOpen-market sale | SELL | $101K 2,500 sh | Jul 1, 2026 traded Jun 30, 2026 |
| 39 | Bettinger Davo Maria FernandaINVESTOR RELATIONS OFFICER |  VTMXVesta Real Estate Corporation, S.A.B. de C.V.Open-market sale | SELL | $72K 21.2K sh | Jul 1, 2026 traded Jun 29, 2026 |
| 36 | Tamayo Louis EdwardChief Financial Officer | LXEOLexeo Therapeutics, Inc. Open-market sale | SELL | $21K 4,641 sh | Jul 1, 2026 traded Jul 1, 2026 |
| 36 | Zafrani EdenCHRO |  NYAXNayax Ltd.Open-market sale | SELL | $32K 500 sh | Jul 1, 2026 traded Jun 30, 2026 |
| 32 | Berho Carranza Lorenzo DominiqueChief Executive Officer | VTMXVesta Real Estate Corporation, S.A.B. de C.V. Open-market sale | SELL | $171K 50.0K sh | Jul 1, 2026 traded Jun 30, 2026 |
| 32 | Berho Carranza Lorenzo DominiqueChief Executive Officer | VTMXVesta Real Estate Corporation, S.A.B. de C.V. Open-market sale | SELL | $171K 50.0K sh | Jul 1, 2026 traded Jun 29, 2026 |
| 32 | Berho Corona Lorenzo ManuelDirector | VTMXVesta Real Estate Corporation, S.A.B. de C.V. Open-market sale | SELL | $171K 50.0K sh | Jul 1, 2026 traded Jun 30, 2026 |
| 32 | Berho Carranza DiegoChief Portfolio Officer | VTMXVesta Real Estate Corporation, S.A.B. de C.V. Open-market sale | SELL | $12K 3,500 sh | Jul 1, 2026 traded Jun 30, 2026 |
| 32 | Otero Jose ManuelChief Operating Officer | LXEOLexeo Therapeutics, Inc. Open-market sale | SELL | $21K 4,666 sh | Jul 1, 2026 traded Jul 1, 2026 |
| 22 | Blumenthal Neil HarrisDirector, Co-Chief Executive Officer |  WRBYWarby Parker Inc.Open-market sale · 10b5-1 plan | SELL | $1.09M 36.3K sh | Jul 1, 2026 traded Jun 29, 2026 |
| 21 | Barone FrancescaChief Scientific Officer |  CADLCandel Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $236K 23.4K sh | Jul 1, 2026 traded Jun 29, 2026 |
| 21 | Paul Josh D.Chief Accounting Officer |  PANWPalo Alto Networks IncOpen-market sale · 10b5-1 plan | SELL | $311K 900 sh | Jul 1, 2026 traded Jul 1, 2026 |
| 20 | Sousa Mauad BrunoDirector | AUGOAura Minerals Inc. Open-market sale | SELL | $552K 26.6K sh | Jul 1, 2026 traded Jun 30, 2026 |
| 19 | ten Bosch John RoderickSVP of Laboratory Operations | BLLNBillionToOne, Inc. Open-market sale · 10b5-1 plan | SELL | $170K 1,416 sh | Jul 1, 2026 traded Jun 29, 2026 |
| 17 | Tyagarajan SeshuChief Technology Officer | CADLCandel Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $70K 7,000 sh | Jul 1, 2026 traded Jun 29, 2026 |
| 14 | Dandekar AtulCSBO | MAZEMaze Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $210K 7,500 sh | Jul 1, 2026 traded Jun 29, 2026 |
| 1 | McNamara PeterChief Scientific Officer |  TECXTectonic Therapeutic, Inc.Open-market sale · 10b5-1 plan | SELL | $6,020 172 sh | Jul 1, 2026 traded Jun 30, 2026 |
| 1 | Clark KyleDirector, SEE REMARKS |  BETABETA Technologies, Inc.Open-market sale · 10b5-1 plan | SELL | $246K 15.0K sh | Jul 1, 2026 traded Jun 29, 2026 |
| 1 | Bliss KellyPresident, U.S. Group Health |  TDOCTeladoc Health, Inc.Open-market sale · 10b5-1 plan | SELL | $23K 2,500 sh | Jul 1, 2026 traded Jul 1, 2026 |
| 1 | Clark KyleDirector, SEE REMARKS | BETABETA Technologies, Inc. Open-market sale · 10b5-1 plan | SELL | $249K 15.0K sh | Jul 1, 2026 traded Jun 30, 2026 |
| 50 | Richmond Raphaell Z.VP, GC & Chief Compliance Off | LZBLA-Z-BOY INC Open-market sale | SELL | $545K 13.7K sh | Jun 30, 2026 traded Jun 29, 2026 |
| 44 | Hunt Jolie A.Director |  NYSEKRCKILROY REALTY CORPOpen-market sale | SELL | $597K 15.8K sh | Jun 30, 2026 traded Jun 29, 2026 |
| 41 | Warren EricChief Commercial Officer |  MLYSMineralys Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $2.70M 104.1K sh | Jun 30, 2026 traded Jun 26, 2026 |
| 40 | Kalia KumudChief Information Officer | GHGuardant Health, Inc. Open-market sale | SELL | $79K 600 sh | Jun 30, 2026 traded Jun 10, 2026 |